Chemistry:TC-2216
From HandWiki
Short description: Chemical compound
This article provides insufficient context for those unfamiliar with the subject. Please help improve the article by providing more context for the reader. (March 2021) (Learn how and when to remove this template message) |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
Chemical and physical data | |
Formula | C12H17N3 |
Molar mass | 203.283 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
TC-2216 is a drug developed by Targacept which acts as a partial agonist at neural nicotinic acetylcholine receptors and was researched for the treatment of anxiety and depression.[1] It was unsuccessful as a therapeutic but is still used in pharmacological research as an alpha4beta2-selective antagonist.[2]
References
- ↑ "Central nicotinic receptors: structure, function, ligands, and therapeutic potential". ChemMedChem 2 (6): 746–67. June 2007. doi:10.1002/cmdc.200600207. PMID 17295372.
- ↑ "TC-5214 (S-(+)-mecamylamine): a neuronal nicotinic receptor modulator with antidepressant activity". CNS Neuroscience & Therapeutics 14 (4): 266–77. 2008. doi:10.1111/j.1755-5949.2008.00054.x. PMID 19040552.
| |||||||||||||||||||||
| |||||||||||||||||||||
| |||||||||||||||||||||
|
5-HT1AR agonists | |
---|---|
GABAAR PAMs |
|
Gabapentinoids (α2δ VDCC blockers) | |
Antidepressants |
|
Sympatholytics (Antiadrenergics) |
|
Others | |
|
nAChRs |
| ||||
---|---|---|---|---|---|
Precursors (and prodrugs) | |||||
0.00 (0 votes)
|